Pharmaceutical companies were fined 150,000 for false propaganda of pharmacies

Indulging in false propaganda by pharmaceutical company personnel, pharmacy fined 150,000 yuan

Indulging in false propaganda by pharmaceutical company personnel, pharmacy fined 150,000 yuan

According to the Hefei Evening News, a pharmacy in Hefei was fined 150,000 yuan by law enforcement agencies recently for indulging drug factory promoters to station in the pharmacy and falsely promoting drugs
.

It is reported that supervision and law enforcement officers checked on April 20 and found that a person wearing a white coat in the pharmacy was helping an elderly person to measure blood pressure.
The measurement also promoted to the elderly the blood pressure and blood lipid-lowering effects of a certain medicine.
A bunch of advertising single pages are placed on the desktop
.

Supervision and law enforcement officers found that the efficacy of the drugs introduced by the blood pressure measurement staff in the pharmacy was seriously inconsistent with the indications on the drug labels and instructions.
In addition, the "Bezoar Qingxin Pill" poster in the pharmacy was also suspected of violating regulations and inconsistent with the contents of the instructions
.

Subsequently, the pharmacy was immediately executed for investigation

After investigation, the blood pressure measurement staff in the above-mentioned pharmacy was actually a salesperson from a pharmaceutical factory in Harbin.
The drug introduced to customers was the prescription drug "Golden Gumi Lecithin Tablets".
The content of the drug leaflet was completely inconsistent with the label on the drug insert.
In addition, the pharmacy was suspected The offending poster was actually placed by a salesperson in a pharmaceutical factory in Shanxi
.

The supervision and law enforcement agency believes that the pharmacy acquiesces and allows drug manufacturer promoters to carry out free drug promotion and promotion activities in its business premises, with the purpose of increasing drug sales, while ordinary consumers cannot distinguish the identity of drug promoters, and false publicity can easily deceive and mislead consumers.
, Resulting in improper medication and disrupting the order of drug management, the pharmacy was given an administrative penalty of 150,000 yuan in accordance with the law
.

The author combed and found that the pharmacy mainly violated the following laws and regulations:

1.
Article 90 of the "Pharmaceutical Administration Law of the People's Republic of China" stipulates that the content of drug advertisements should be true and legal, subject to the drug instructions approved by the drug regulatory department of the State Council, and must not contain false content
.

2.
Article 3 of the "Interim Measures for the Administration of the Review of Advertisements for Drugs, Medical Devices, Health Foods, and Formulas for Special Medical Purposes" stipulates that drug advertisements must not contain false or misleading content, and advertisers shall be responsible for the authenticity and legality of the advertisements
.

3.
Article 8 of the Anti-Unfair Competition Law of the People's Republic of China stipulates that operators shall not make false or misleading commercial publicity on the performance, function, quality, sales status, user evaluation, honors, etc.
of their products.
Deceive and mislead consumers
.

4.
Penalties related to the "Advertising Law of the People's Republic of China": Those who publish false advertisements shall be fined three times to five times the advertising cost.
If the advertising cost cannot be calculated or is obviously low, 200,000 yuan and 1 million yuan shall be imposed.
The following is fine
.

Separation of medicine, pharmacies beware of being "PR"

Separation of medicine, pharmacies beware of being "PR"

According to data from Zhongkang CMH, with the liberalization of relevant policies such as prescription outflow and separation of medicines, the proportion of pharmacy terminals in the entire drug terminal market will be significantly increased, from 20% in 2020 to 25% in 2030
.

With the announcement and implementation of relevant policies, the retail pharmacy market will usher in a lot of growth, but it will also provide a breeding ground for industry corruption and bribery

In an interview with the People’s Daily, the deputy dean of a tertiary hospital in Huangpu District said that after the release of the policy on separation of medicines, it is necessary to further prevent the main body of public relations doctors from turning from pharmaceutical companies to pharmacies
.

3 common illegal advertisements, pharmacies should pay attention to

3 common illegal advertisements, pharmacies should pay attention to

In fact, during the operation of pharmacies, there are three most common advertising violations, which are often exposed by regulatory authorities and the media
.

1.
Exaggerate the effects of drugs

Recently, the Market Supervision Bureau of Sichuan Meishan City announced a typical case of illegal advertising in pharmacies
.

The posters produced and released by the pharmacies contain false content: 1.

Regarding the authenticity of the efficacy of the above-mentioned drugs, the pharmacy was unable to provide proof materials or relevant basis
.

In response, the relevant regulatory authorities ordered it to immediately stop publishing illegal advertisements and imposed a fine of RMB 5,000

2.
Drug purchase promotion

According to the Jiangnan Evening News, a pharmacy in the city recently used prescription drugs to participate in promotional activities such as "Buy × Give ×" and "Redeem for purchases over RMB ×" and was suspected of breaking the law
.

According to the "Measures for the Supervision and Administration of Drug Circulation", drug manufacturers and distributors are not allowed to donate prescription drugs or Class A non-prescription drugs to the public in ways such as tie-in sales, drug purchases to give drugs, and commodity purchases to give drugs to the public

3.
Advertise prescription drugs

In April of this year, the Nanguo Morning Post reported that two pharmacies in Nanning posted advertisements about sex drugs in prominent locations, but they did not know that the behavior was illegal, and the relevant departments ordered rectification
.

According to experts, the dapoxetine hydrochloride tablets involved in the above-mentioned sex drugs are prescription drugs prescribed by the state, and prescription drugs can only be advertised in medical and pharmaceutical publications jointly designated by the health administration department of the State Council and the drug regulatory department of the State Council